Literature DB >> 21467215

HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII.

Simon D van Haren1, Eszter Herczenik, Anja ten Brinke, Koen Mertens, Jan Voorberg, Alexander B Meijer.   

Abstract

Activation of T-helper cells is dependent upon the appropriate presentation of antigen-derived peptides on MHC class II molecules expressed on antigen presenting cells. In the current study we explored the repertoire of peptides presented on MHC class II molecules on human monocyte derived dendritic cells (moDCs) from four HLA-typed healthy donors. MHC class II-bound peptides could be routinely recovered from small cultures containing 5 × 10(6) cells. A fraction of the identified peptides were derived from proteins localized in the plasma membrane, endosomes, and lysosomes, but the majority of peptides that were presented on MHC class II originate from other organelles. Subsequently, we studied the antigen-specific peptide repertoire after endocytosis of a soluble antigen. Blood coagulation factor VIII (FVIII) was chosen as the antigen since our current knowledge on MHC class II presented peptides derived from this immunogenic therapeutic protein is limited. Analysis of the total repertoire of MHC class II-associated peptides revealed that per individual sample 20-50 FVIII-derived peptides were presented on FVIII-pulsed moDCs. Repertoires of FVIII-derived peptides eluted from moDCs derived from a panel of four HLA typed donors revealed that some MHC class II-presented FVIII peptides were presented by multiple donors, whereas the presentation of other FVIII peptides was donor-specific. In total 32 different core peptides were presented on FVIII-pulsed moDCs from four HLA-typed donors. Together our findings provide an unbiased approach to identify peptides that are presented by MHC class II on antigen-loaded moDCs from individual donors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467215      PMCID: PMC3108829          DOI: 10.1074/mcp.M110.002246

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  47 in total

1.  Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes.

Authors:  Dorothee Schmid; Marc Pypaert; Christian Münz
Journal:  Immunity       Date:  2006-12-21       Impact factor: 31.745

2.  Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis.

Authors:  Miguel A Sanjuan; Christopher P Dillon; Stephen W G Tait; Simon Moshiach; Frank Dorsey; Samuel Connell; Masaaki Komatsu; Keiji Tanaka; John L Cleveland; Sebo Withoff; Douglas R Green
Journal:  Nature       Date:  2007-12-20       Impact factor: 49.962

Review 3.  Endocytosis mechanisms and the cell biology of antigen presentation.

Authors:  Sven Burgdorf; Christian Kurts
Journal:  Curr Opin Immunol       Date:  2008-01-30       Impact factor: 7.486

4.  The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization.

Authors:  Anja Ten Brinke; Miriam L Karsten; Miranda C Dieker; Jaap Jan Zwaginga; S Marieke van Ham
Journal:  Vaccine       Date:  2007-08-06       Impact factor: 3.641

5.  T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptide.

Authors:  E A James; W W Kwok; R A Ettinger; A R Thompson; K P Pratt
Journal:  J Thromb Haemost       Date:  2007-12       Impact factor: 5.824

6.  Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.

Authors:  Jan Wahlström; Jörn Dengjel; Bengt Persson; Hüseyin Duyar; Hans-Georg Rammensee; Stefan Stevanović; Anders Eklund; Robert Weissert; Johan Grunewald
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

7.  A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes.

Authors:  Suryasarathi Dasgupta; Ana-Maria Navarrete; Jagadeesh Bayry; Sandrine Delignat; Bharath Wootla; Sébastien André; Olivier Christophe; Michelina Nascimbeni; Marc Jacquemin; Luisa Martinez-Pomares; Teunis B H Geijtenbeek; Arnaud Moris; Jean-Marie Saint-Remy; Michel D Kazatchkine; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-14       Impact factor: 11.205

8.  A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach.

Authors:  Peng Wang; John Sidney; Courtney Dow; Bianca Mothé; Alessandro Sette; Bjoern Peters
Journal:  PLoS Comput Biol       Date:  2008-04-04       Impact factor: 4.475

9.  Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.

Authors:  Morten Nielsen; Claus Lundegaard; Ole Lund
Journal:  BMC Bioinformatics       Date:  2007-07-04       Impact factor: 3.169

10.  The MHC class I peptide repertoire is molded by the transcriptome.

Authors:  Marie-Hélène Fortier; Etienne Caron; Marie-Pierre Hardy; Grégory Voisin; Sébastien Lemieux; Claude Perreault; Pierre Thibault
Journal:  J Exp Med       Date:  2008-02-25       Impact factor: 14.307

View more
  29 in total

1.  von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIII.

Authors:  Nicoletta Sorvillo; Robin B Hartholt; Esther Bloem; Magdalena Sedek; Anja ten Brinke; Carmen van der Zwaan; Floris P van Alphen; Alexander B Meijer; Jan Voorberg
Journal:  Haematologica       Date:  2015-12-03       Impact factor: 9.941

Review 2.  Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development.

Authors:  Laura I Salazar-Fontana; Dharmesh D Desai; Tarik A Khan; Renuka C Pillutla; Sandra Prior; Radha Ramakrishnan; Jennifer Schneider; Alexandra Joseph
Journal:  AAPS J       Date:  2017-01-12       Impact factor: 4.009

3.  Factor VIII gene variants and inhibitor risk in African American hemophilia A patients.

Authors:  Devi Gunasekera; Ruth A Ettinger; Shelley Nakaya Fletcher; Eddie A James; Maochang Liu; John C Barrett; Janice Withycombe; Dana C Matthews; Melinda S Epstein; Richard J Hughes; Kathleen P Pratt
Journal:  Blood       Date:  2015-01-23       Impact factor: 22.113

4.  The human leukocyte antigen-presented ligandome of B lymphocytes.

Authors:  Chopie Hassan; Michel G D Kester; Arnoud H de Ru; Pleun Hombrink; Jan Wouter Drijfhout; Harm Nijveen; Jack A M Leunissen; Mirjam H M Heemskerk; J H Frederik Falkenburg; Peter A van Veelen
Journal:  Mol Cell Proteomics       Date:  2013-03-12       Impact factor: 5.911

5.  Mass spectrometry-assisted study reveals that lysine residues 1967 and 1968 have opposite contribution to stability of activated factor VIII.

Authors:  Esther Bloem; Henriet Meems; Maartje van den Biggelaar; Carmen van der Zwaan; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

6.  T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire.

Authors:  Ruth A Ettinger; Pedro Paz; Eddie A James; Devi Gunasekera; Fred Aswad; Arthur R Thompson; Dana C Matthews; Kathleen P Pratt
Journal:  Blood       Date:  2016-07-28       Impact factor: 22.113

7.  CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.

Authors:  Katharina N Steinitz; Pauline M van Helden; Brigitte Binder; David C Wraith; Sabine Unterthurner; Corinna Hermann; Maria Schuster; Rafi U Ahmad; Markus Weiller; Christian Lubich; Maurus de la Rosa; Hans Peter Schwarz; Birgit M Reipert
Journal:  Blood       Date:  2012-03-06       Impact factor: 22.113

8.  Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice.

Authors:  Weiqing Jing; Juan Chen; Yuanhua Cai; Yingyu Chen; Jocelyn A Schroeder; Bryon D Johnson; Weiguo Cui; Qizhen Shi
Journal:  Blood Adv       Date:  2019-10-22

9.  Distinct roles of Ser-764 and Lys-773 at the N terminus of von Willebrand factor in complex assembly with coagulation factor VIII.

Authors:  Lydia Castro-Núñez; Esther Bloem; Mariëtte G Boon-Spijker; Carmen van der Zwaan; Maartje van den Biggelaar; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2012-11-20       Impact factor: 5.157

10.  Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products.

Authors:  Wojciech Jankowski; Yara Park; Joseph McGill; Eugene Maraskovsky; Marco Hofmann; Vincent P Diego; Bernadette W Luu; Tom E Howard; Roberta Kellerman; Nigel S Key; Zuben E Sauna
Journal:  Blood Adv       Date:  2019-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.